HCW Biologics Inc. (NASDAQ:HCWB) filed a Form 8-K with the Securities and Exchange Commission on February 19, 2026, disclosing a material event.
HCW Biologics Inc.'s stock currently trades at $0.60 with a market capitalization of $4.3M. The Healthcare company's stock moved following the disclosure.